{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T22:30:43Z","timestamp":1786487443707,"version":"build-2736575974"},"reference-count":196,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004054","name":"King Abdulaziz University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021772","name":"Deanship of Scientific Research, University of Jordan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021772","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejphar.2026.179130","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T19:56:10Z","timestamp":1783626970000},"page":"179130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cannabinoids in peripheral neuropathic pain: Resolving mechanistic mismatch through CB2-oriented phenotype stratification"],"prefix":"10.1016","volume":"1030","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1850-5686","authenticated-orcid":false,"given":"Amina M.","family":"Bagher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.179130_bib1","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nn1916","article-title":"Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors","volume":"10","author":"Agarwal","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179130_bib2","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3390\/biom15060816","article-title":"Are cannabis-based medicines a useful treatment for neuropathic pain? A systematic review","volume":"15","author":"Almuntashiri","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejphar.2026.179130_bib3","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.2337\/dc24-S002","article-title":"2. Diagnosis and classification of diabetes: standards of care in Diabetes-2024","volume":"47","author":"American","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2026.179130_bib4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.redox.2014.01.006","article-title":"Oxidative stress and nerve damage: role in chemotherapy induced peripheral neuropathy","volume":"2","author":"Areti","year":"2014","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2026.179130_bib5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/jns.12616","article-title":"Incidence and risk factors for developing chemotherapy\u2010induced neuropathic pain in 500 cancer patients: a file\u2010based observational study","volume":"29","author":"Argyriou","year":"2024","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.ejphar.2026.179130_bib6","article-title":"Cannabis-based medicines for chronic neuropathic pain in adults","author":"Ate\u015f","year":"2026","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejphar.2026.179130_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bja.2023.04.021","article-title":"Advances and challenges in neuropathic pain: a narrative review and future directions","volume":"131","author":"Attal","year":"2023","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ejphar.2026.179130_bib8","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S1474-4422(16)00017-X","article-title":"Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial","volume":"15","author":"Attal","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejphar.2026.179130_bib9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1476-5381.2010.00729.x","article-title":"CB2 : a cannabinoid receptor with an identity crisis","volume":"160","author":"Atwood","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179130_bib10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jneuroim.2010.08.013","article-title":"The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines","volume":"229","author":"Austin","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ejphar.2026.179130_bib11","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.3390\/cimb45040228","article-title":"Cannabis pharmacogenomics: a path to personalized medicine","volume":"45","author":"Babayeva","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.ejphar.2026.179130_bib12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11920-017-0775-9","article-title":"Cannabis, cannabinoids, and sleep: a review of the literature","volume":"19","author":"Babson","year":"2017","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.ejphar.2026.179130_bib13","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.3390\/ijms26094430","article-title":"Intraplantar \u03b2-Caryophyllene alleviates pain and inflammation in STZ-induced diabetic peripheral neuropathy via CB2 receptor activation","volume":"26","author":"Bagher","year":"2025","journal-title":"IJMS"},{"key":"10.1016\/j.ejphar.2026.179130_bib14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jsps.2022.12.011","article-title":"Cannabinoid receptor 1 positive allosteric modulator (GAT229) attenuates cisplatin-induced neuropathic pain in mice","volume":"31","author":"Bagher","year":"2023","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.ejphar.2026.179130_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41582-022-00741-7","article-title":"Maximizing treatment efficacy through patient stratification in neuropathic pain trials","volume":"19","author":"Baron","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ejphar.2026.179130_bib16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/j.pain.0000000000000753","article-title":"Peripheral neuropathic pain: a mechanism-related organizing principle based on sensory profiles","volume":"158","author":"Baron","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2026.179130_bib17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cell.2009.09.028","article-title":"Cellular and molecular mechanisms of pain","volume":"139","author":"Basbaum","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2026.179130_bib18","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/npp.2011.6","article-title":"Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-na\u00efve social phobia patients","volume":"36","author":"Bergamaschi","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2026.179130_bib19","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.pain.2004.09.013","article-title":"Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial","volume":"112","author":"Berman","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2026.179130_bib20","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.chembiol.2007.11.006","article-title":"A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-Arachidonoylglycerol","volume":"14","author":"Blankman","year":"2007","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejphar.2026.179130_bib21","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.3390\/biomedicines11061546","article-title":"The selective CB2 agonist COR167 reduced symptoms in a mice model of trauma-induced peripheral neuropathy through HDAC-1 inhibition","volume":"11","author":"Borgonetti","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejphar.2026.179130_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pain.2004.12.010","article-title":"Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4)","volume":"114","author":"Bouhassira","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2026.179130_bib23","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.pain.2003.12.024","article-title":"Development and validation of the neuropathic pain symptom inventory","volume":"108","author":"Bouhassira","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2026.179130_bib24","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/ejp.2120","article-title":"Personalized treatment of neuropathic pain: where are we now?","volume":"27","author":"Bouhassira","year":"2023","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.ejphar.2026.179130_bib25","article-title":"Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline","volume":"n2040","author":"Busse","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ejphar.2026.179130_bib26","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1474-4422(12)70065-0","article-title":"Diabetic neuropathy: clinical manifestations and current treatments","volume":"11","author":"Callaghan","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejphar.2026.179130_bib27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fnbeh.2012.00073","article-title":"The endocannabinoid system: a key modulator of emotions and cognition","volume":"6","author":"Campolongo","year":"2012","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179130_bib28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/ejp.2165","article-title":"The effect of lacosamide in peripheral neuropathic pain: a randomized, double\u2010blind, placebo\u2010controlled, phenotype\u2010stratified trial","volume":"28","author":"Carmland","year":"2024","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.ejphar.2026.179130_bib29","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuron.2012.09.020","article-title":"Endocannabinoid signaling and synaptic function","volume":"76","author":"Castillo","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2026.179130_bib30","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1097\/j.pain.0000000000002314","article-title":"Olorinab (APD371), a peripherally acting, highly selective, full agonist of the cannabinoid receptor 2, reduces colitis-induced acute and chronic visceral hypersensitivity in rodents","volume":"163","author":"Castro","year":"2022","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2026.179130_bib31","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nrneurol.2010.160","article-title":"Chemotherapy-induced peripheral neurotoxicity","volume":"6","author":"Cavaletti","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ejphar.2026.179130_bib32","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14539","article-title":"Efficacy and safety of olorinab, a full agonist of the cannabinoid receptor 2, for the treatment of abdominal pain in patients with irritable bowel syndrome: results from a phase 2b randomized placebo\u2010controlled trial (CAPTIVATE)","volume":"35","author":"Chang","year":"2023","journal-title":"Neurogastroenterology Motil"},{"key":"10.1016\/j.ejphar.2026.179130_bib33","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/hmg\/ddh216","article-title":"Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use","volume":"13","author":"Chiang","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejphar.2026.179130_bib34","series-title":"Living Systematic Review on Cannabis and Other Plant-based Treatments for Chronic Pain: 2025 Update (Comparative Effectiveness Review No. No. 250; AHRQ Publication No. 25-EHC036)","author":"Chou","year":"2025"},{"key":"10.1016\/j.ejphar.2026.179130_bib35","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/nn.2632","article-title":"Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism","volume":"13","author":"Clapper","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179130_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.2","article-title":"Neuropathic pain","volume":"3","author":"Colloca","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ejphar.2026.179130_bib37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0269881110379283","article-title":"Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report","volume":"25","author":"Crippa","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2026.179130_bib38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","article-title":"Cannabinoids and the expanded endocannabinoid system in neurological disorders","volume":"16","author":"Cristino","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ejphar.2026.179130_bib39","first-page":"e1556","article-title":"Topical cannabidiol for established chemotherapy-induced neuropathy: a pilot randomized placebo-controlled trial","volume":"9","author":"D'Andre","year":"2024","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.ejphar.2026.179130_bib40","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1476-5381.2010.01166.x","article-title":"Effects of cannabinoids and cannabinoid\u2010enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes","volume":"163","author":"De Petrocellis","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179130_bib41","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.pain.2014.08.014","article-title":"The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: a randomised, double-blind, placebo-controlled phenotype-stratified study","volume":"155","author":"Demant","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2026.179130_bib42","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/npp.2017.204","article-title":"The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain","volume":"43","author":"Donvito","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2026.179130_bib43","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1208\/s12248-021-00616-7","article-title":"Cannabinoid interactions with cytochrome P450 drug metabolism: a full-spectrum characterization","volume":"23","author":"Doohan","year":"2021","journal-title":"AAPS J."},{"key":"10.1016\/j.ejphar.2026.179130_bib44","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.pain.2009.08.019","article-title":"Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations","volume":"146","author":"Dworkin","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2026.179130_bib45","series-title":"Guideline on Multiplicity Issues in Clinical Trials (No. EMA\/CHMP\/44762\/2017)","year":"2017"},{"key":"10.1016\/j.ejphar.2026.179130_bib46","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1093\/brain\/awt053","article-title":"Small fibre pathology in patients with fibromyalgia syndrome","volume":"136","author":"\u00dc\u00e7eyler","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.ejphar.2026.179130_bib47","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2174\/1570159X17666190903103923","article-title":"The \u201centourage effect\u201d: terpenes coupled with cannabinoids for the treatment of mood disorders and anxiety disorders","volume":"18","author":"Ferber","year":"2020","journal-title":"CN"},{"key":"10.1016\/j.ejphar.2026.179130_bib48","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1006\/nbdi.1998.0204","article-title":"Postherpetic neuralgia: irritable nociceptors and deafferentation","volume":"5","author":"Fields","year":"1998","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2026.179130_bib49","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/npp.2009.200","article-title":"Individual and additive effects of the CNR1 and FAAH genes on brain response to Marijuana Cues","volume":"35","author":"Filbey","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2026.179130_bib50","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejphar.2026.179130_bib51","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1097\/j.pain.0000000000000492","article-title":"Neuropathic pain: an updated grading system for research and clinical practice","volume":"157","author":"Finnerup","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2026.179130_bib52","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1152\/physrev.00045.2019","article-title":"Neuropathic pain: from mechanisms to treatment","volume":"101","author":"Finnerup","year":"2021","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2026.179130_bib53","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1185\/030079906X132488","article-title":"Pain DETECT : a new screening questionnaire to identify neuropathic components in patients with back pain","volume":"22","author":"Freynhagen","year":"2006","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.ejphar.2026.179130_bib54","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nri3621","article-title":"Pathological pain and the neuroimmune interface","volume":"14","author":"Grace","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2026.179130_bib55","doi-asserted-by":"crossref","first-page":"218","DOI":"10.56367\/OAG-039-10485","article-title":"CB2R agonists in the clinics: a treasure chest for treating inflammatory diseases","volume":"39","author":"Grether","year":"2023","journal-title":"Open Access Government"},{"key":"10.1016\/j.ejphar.2026.179130_bib56","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","article-title":"Pharmacokinetics and pharmacodynamics of cannabinoids","volume":"42","author":"Grotenhermen","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejphar.2026.179130_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.110257","article-title":"The cannabinoid CB2 agonist LY2828360 suppresses neuropathic pain behavior and attenuates morphine tolerance and conditioned place preference in rats","volume":"265","author":"Guenther","year":"2025","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2026.179130_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109601","article-title":"Conditional deletion of CB2 cannabinoid receptors from peripheral sensory neurons eliminates CB2-mediated antinociceptive efficacy in a mouse model of carrageenan-induced inflammatory pain","volume":"237","author":"Guenther","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2026.179130_bib59","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.bjp.0707531","article-title":"Cannabinoid CB 2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain: cannabinoid CB 2 mechanisms of pain suppression","volume":"153","author":"Guindon","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179130_bib60","doi-asserted-by":"crossref","DOI":"10.1177\/20503121231218985","article-title":"Shedding light on neuropathic pain: current and emerging tools for diagnosis, screening, and quantification","volume":"12","author":"Hamdan","year":"2024","journal-title":"SAGE Open Med."},{"key":"10.1016\/j.ejphar.2026.179130_bib61","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/ejp.818","article-title":"Transdermal cannabidiol reduces inflammation and pain\u2010related behaviours in a rat model of arthritis","volume":"20","author":"Hammell","year":"2016","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.ejphar.2026.179130_bib62","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41583-020-0333-z","article-title":"Emerging importance of satellite glia in nervous system function and dysfunction","volume":"21","author":"Hanani","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179130_bib63","first-page":"28","article-title":"Oral Cannabis for taxane-induced neuropathy: a pilot randomized placebo-controlled Study","volume":"2025","author":"Haney","year":"2025","journal-title":"Cannabis and Cannabinoid Research can"},{"key":"10.1016\/j.ejphar.2026.179130_bib64","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13685","article-title":"Pharmacokinetics and pharmacodynamics of cannabis-based medicine in a patient population included in a randomized, placebo-controlled, clinical trial","volume":"17","author":"Hansen","year":"2024","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.ejphar.2026.179130_bib65","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1002\/eji.201040667","article-title":"Cannabinoid receptor activation leads to massive mobilization of myeloid\u2010derived suppressor cells with potent immunosuppressive properties","volume":"40","author":"Hegde","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ejphar.2026.179130_bib66","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/nature03658","article-title":"An endocannabinoid mechanism for stress-induced analgesia","volume":"435","author":"Hohmann","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2026.179130_bib67","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0306-4522(99)00220-1","article-title":"Cannabinoid receptors undergo axonal flow in sensory nerves","volume":"92","author":"Hohmann","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2026.179130_bib68","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.3390\/ijms21041423","article-title":"Targeting peripherally restricted cannabinoid receptor 1, cannabinoid receptor 2, and endocannabinoid-degrading enzymes for the treatment of neuropathic pain including neuropathic orofacial pain","volume":"21","author":"Hossain","year":"2020","journal-title":"IJMS"},{"key":"10.1016\/j.ejphar.2026.179130_bib69","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/cbdv.200790152","article-title":"Human cannabinoid pharmacokinetics","volume":"4","author":"Huestis","year":"2007","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejphar.2026.179130_bib70","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.pain.2012.04.020","volume":"153","author":"Huggins","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2026.179130_bib71","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/ejp.1736","article-title":"European\u2217 clinical practice recommendations on opioids for chronic noncancer pain - part 1: role of opioids in the management of chronic noncancer pain","volume":"25","author":"H\u00e4user","year":"2021","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.ejphar.2026.179130_bib72","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ejp.1118","article-title":"Efficacy, tolerability and safety of cannabis\u2010based medicines for chronic pain management \u2013 an overview of systematic reviews","volume":"22","author":"H\u00e4user","year":"2018","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.ejphar.2026.179130_bib73","first-page":"48","volume":"2","author":"Ibsen","year":"2017"},{"key":"10.1016\/j.ejphar.2026.179130_bib74","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1089\/can.2016.0037","article-title":"Cannabinoid CB1 and CB2 receptor signaling and bias","volume":"2","author":"Ibsen","year":"2017","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.ejphar.2026.179130_bib75","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1038\/npp.2015.148","article-title":"A cannabinoid CB1 receptor-positive allosteric modulator reduces neuropathic pain in the mouse with no psychoactive effects","volume":"40","author":"Ignatowska-Jankowska","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2026.179130_bib76","series-title":"Comprehensive Medicinal Chemistry","first-page":"635","article-title":"Cannabinoid receptors as targets for drug discovery","author":"Iliopoulos-Tsoutsouvas","year":"2026"},{"key":"10.1016\/j.ejphar.2026.179130_bib77","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S1474-4422(14)70102-4","article-title":"Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms","volume":"13","author":"Jensen","year":"2014","journal-title":"Lancet Neurol."},{"issue":"26","key":"10.1016\/j.ejphar.2026.179130_bib78","article-title":"CB2 cannabinoid receptor-specific therapeutic antibody agonists for treatment of chemotherapy-induced peripheral neuropathy","volume":"11","author":"Jesus","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.ejphar.2026.179130_bib79","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1111\/j.1460-9568.2008.06162.x","article-title":"Evidence for a novel functional role of cannabinoid CB2 receptors in the thalamus of neuropathic rats","volume":"27","author":"Jhaveri","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179130_bib80","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1126\/science.aaf8924","article-title":"Pain regulation by non-neuronal cells and inflammation","volume":"354","author":"Ji","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2026.179130_bib81","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/ALN.0000000000002130","article-title":"Neuroinflammation and central sensitization in chronic and widespread pain","volume":"129","author":"Ji","year":"2018","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejphar.2026.179130_bib82","doi-asserted-by":"crossref","first-page":"8039","DOI":"10.1038\/s41467-023-43606-3","article-title":"A monoacylglycerol lipase inhibitor showing therapeutic efficacy in mice without central side effects or dependence","volume":"14","author":"Jiang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.179130_bib83","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMcp1403062","article-title":"Postherpetic neuralgia","volume":"371","author":"Johnson","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2026.179130_bib84","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1038\/s41591-025-03977-0","article-title":"Full-spectrum extract from Cannabis sativa DKJ127 for chronic low back pain: a phase 3 randomized placebo-controlled trial","volume":"31","author":"Karst","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2026.179130_bib85","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1021\/acsmedchemlett.5b00353","article-title":"Preclinical characterization of the FAAH inhibitor JNJ-42165279","volume":"6","author":"Keith","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2026.179130_bib86","doi-asserted-by":"crossref","first-page":"523","DOI":"10.37349\/ei.2024.00156","article-title":"Evolving role of immunology in chronic pain medicine: tissue necrosis factor and interleukin modulatory treatments","author":"Kelkar","year":"2024","journal-title":"Explor Immunol"},{"key":"10.1016\/j.ejphar.2026.179130_bib87","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1056\/NEJMoa1604221","article-title":"Acute neurologic disorder from an inhibitor of fatty Acid Amide hydrolase","volume":"375","author":"Kerbrat","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2026.179130_bib88","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/CORR.0000000000003221","article-title":"Does cannabis-based medicine improve pain and sleep quality in patients with traumatic brachial plexus injuries? A triple-blind, crossover, randomized controlled trial","volume":"483","author":"Kittithamvongs","year":"2025","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.ejphar.2026.179130_bib89","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.euroneuro.2013.10.008","article-title":"The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain","volume":"24","author":"Klauke","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2026.179130_bib90","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/s41386-024-02001-2","article-title":"Efficacy and safety of JNJ-42165279, a fatty acid amide hydrolase inhibitor, in adolescents and adults with autism spectrum disorder: a randomized, phase 2, placebo-controlled study","volume":"50","author":"Klein","year":"2025","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2026.179130_bib91","article-title":"Plasma and interstitial levels of endocannabinoids and N-acylethanolamines in patients with chronic widespread pain and fibromyalgia: a systematic review and meta-analysis","volume":"7","author":"Kurlyandchik","year":"2022","journal-title":"Pain Rep"},{"key":"10.1016\/j.ejphar.2026.179130_bib92","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179130_bib93","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1097\/j.pain.0000000000003278","article-title":"Peripherally restricted cannabinoid and mu-opioid receptor agonists synergistically attenuate neuropathic mechanical hypersensitivity in mice","volume":"165","author":"Limerick","year":"2024","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2026.179130_bib94","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1124\/mol.117.109355","article-title":"Slowly signaling G protein\u2013biased CB2 cannabinoid receptor agonist LY2828360 suppresses neuropathic pain with sustained efficacy and attenuates morphine tolerance and dependence","volume":"93","author":"Lin","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179130_bib95","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1124\/mol.104.006353","article-title":"The nuclear receptor peroxisome proliferator-activated Receptor-\u03b1 mediates the anti-inflammatory actions of palmitoylethanolamide","volume":"67","author":"Lo Verme","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179130_bib96","first-page":"3325","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update","volume":"38","author":"Loprinzi","year":"2020","journal-title":"J. Clin. Orthod."},{"key":"10.1016\/j.ejphar.2026.179130_bib97","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jpainsymman.2013.02.018","article-title":"A double-blind, placebo-controlled, crossover pilot trial with extension using an oral mucosal cannabinoid extract for treatment of chemotherapy-induced neuropathic pain","volume":"47","author":"Lynch","year":"2014","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.ejphar.2026.179130_bib98","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.2174\/138161208785740045","article-title":"Endocannabinoid signaling and neuroinflammatory diseases","volume":"14","author":"Maccarrone","year":"2008","journal-title":"CPD"},{"key":"10.1016\/j.ejphar.2026.179130_bib99","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1124\/pharmrev.122.000600","article-title":"Goods and bads of the endocannabinoid system as a therapeutic target: lessons learned after 30 years","volume":"75","author":"Maccarrone","year":"2023","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2026.179130_bib100","doi-asserted-by":"crossref","first-page":"33896","DOI":"10.1074\/jbc.M303994200","article-title":"The endocannabinoid system in human keratinocytes. Evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activation protein-1, and transglutaminase","volume":"278","author":"Maccarrone","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2026.179130_bib101","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s40263-024-01098-9","article-title":"The state of synthetic cannabinoid medications for the treatment of pain","volume":"38","author":"Maglaviceanu","year":"2024","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejphar.2026.179130_bib102","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.pain.2010.05.002","article-title":"Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes","volume":"150","author":"Maier","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2026.179130_bib103","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0304-3959(01)00321-9","article-title":"CB2 cannabinoid receptor-mediated peripheral antinociception","volume":"93","author":"Malan","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2026.179130_bib104","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1515\/sjpain-2019-0138","article-title":"Role of the immune system in neuropathic pain","volume":"20","author":"Malcangio","year":"2019","journal-title":"Scandinavian Journal of Pain"},{"key":"10.1016\/j.ejphar.2026.179130_bib105","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.sleep.2018.05.023","article-title":"Sleep disturbances and sleep disorders in adults living with chronic pain: a meta-analysis","volume":"52","author":"Mathias","year":"2018","journal-title":"Sleep Med."},{"key":"10.1016\/j.ejphar.2026.179130_bib106","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3390\/life14080991","article-title":"Chemotherapy-Induced peripheral neuropathy: a recent update on pathophysiology and treatment","volume":"14","author":"Mattar","year":"2024","journal-title":"Life"},{"key":"10.1016\/j.ejphar.2026.179130_bib107","series-title":"Living Systematic Review on Cannabis and Other Plant-based Treatments for Chronic Pain (No. Comparative Effectiveness Review No. 250; AHRQ Publication No. 21(22)-EHC036)","author":"McDonagh","year":"2021"},{"key":"10.1016\/j.ejphar.2026.179130_bib108","article-title":"Cannabis-based medicines for chronic neuropathic pain in adults","volume":"3","author":"M\u00fccke","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejphar.2026.179130_bib109","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s40122-025-00773-z","article-title":"VER-01 shows enhanced gastrointestinal tolerability, superior pain relief, and improved sleep quality compared to opioids in treating chronic low back pain: a randomized phase 3 clinical trial","volume":"14","author":"Meissner","year":"2025","journal-title":"Pain Ther."},{"key":"10.1016\/j.ejphar.2026.179130_bib110","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1213\/ANE.0000000000002110","article-title":"Selective cannabinoids for chronic neuropathic pain: a systematic review and meta-analysis","volume":"125","author":"Meng","year":"2017","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ejphar.2026.179130_bib111","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.3389\/fphar.2018.01365","article-title":"A systematic review on the pharmacokinetics of cannabidiol in humans","volume":"9","author":"Millar","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179130_bib112","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/15504263.2019.1668100","article-title":"Cannabinoid receptor type 1 and its role as an analgesic: an opioid alternative?","volume":"16","author":"Milligan","year":"2020","journal-title":"J. Dual Diagn."},{"key":"10.1016\/j.ejphar.2026.179130_bib113","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.pain.2006.06.016","article-title":"Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain","volume":"126","author":"Mitrirattanakul","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2026.179130_bib114","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1055\/a-1675-3494","article-title":"Endocannabinoid modulation using monoacylglycerol lipase inhibition in Tourette syndrome: a phase 1 randomized, placebo-controlled study","volume":"55","author":"M\u00fcller-Vahl","year":"2022","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.ejphar.2026.179130_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.lpm.2024.104232","article-title":"Neuropathic pain: evidence based recommendations","volume":"53","author":"Moisset","year":"2024","journal-title":"Presse Med."},{"key":"10.1016\/j.ejphar.2026.179130_bib116","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jpain.2023.10.009","article-title":"Cannabidiol (CBD) products for pain: ineffective, expensive, and with potential harms","volume":"25","author":"Moore","year":"2024","journal-title":"J. Pain"},{"key":"10.1016\/j.ejphar.2026.179130_bib117","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/archneur.61.4.546","article-title":"HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the manhattan HIV brain bank","volume":"61","author":"Morgello","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ejphar.2026.179130_bib118","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1124\/dmd.121.000442","article-title":"Cannabinoid metabolites as inhibitors of major hepatic CYP450 enzymes, with implications for cannabis-drug interactions","volume":"49","author":"Nasrin","year":"2021","journal-title":"Drug Metabol. Dispos."},{"key":"10.1016\/j.ejphar.2026.179130_bib119","article-title":"A Phase II RCT of oral cannabinoid versus placebo in the treatment of chemotherapy-induced peripheral neuropathic pain (ACTION) (ongoing clinical trial (protocol) no. NIHR151052)","year":"2024","journal-title":"National Institute for Health and Care Research"},{"key":"10.1016\/j.ejphar.2026.179130_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsycho.2021.108022","article-title":"Endocannabinoid reactivity to acute stress: investigation of the relationship between salivary and plasma levels","volume":"159","author":"Ney","year":"2021","journal-title":"Biol. Psychol."},{"key":"10.1016\/j.ejphar.2026.179130_bib121","first-page":"9441","article-title":"Oral cannabidiol for prevention of acute and transient chemotherapy-induced peripheral neuropathy","volume":"30","author":"Nielsen","year":"2022","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.ejphar.2026.179130_bib122","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/1352458511419700","article-title":"A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term sativex\u00ae (nabiximols)","volume":"18","author":"Notcutt","year":"2012","journal-title":"Mult. Scler."},{"key":"10.1016\/j.ejphar.2026.179130_bib123","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.pain.2007.08.028","article-title":"Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial","volume":"133","author":"Nurmikko","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2026.179130_bib124","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/bph.13497","article-title":"An update on PPAR activation by cannabinoids","volume":"173","author":"O'Sullivan","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179130_bib125","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1016\/j.bmcl.2012.02.072","article-title":"Discovery of S-777469: an orally available CB2 agonist as an antipruritic agent","volume":"22","author":"Odan","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejphar.2026.179130_bib126","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1097\/AJP.0b013e318219799a","article-title":"A randomized, controlled study to investigate the analgesic efficacy of single doses of the cannabinoid Receptor-2 agonist GW842166, ibuprofen or placebo in patients with acute pain following third molar tooth extraction","volume":"27","author":"Ostenfeld","year":"2011","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.ejphar.2026.179130_bib127","series-title":"OCTP Successfully Completes Phase 1 Trial of OCT461201 (Regulatory News Service Announcement). Oxford Cannabinoid Technologies Holdings Plc","year":"2023"},{"key":"10.1016\/j.ejphar.2026.179130_bib128","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1016\/j.jid.2023.05.025","article-title":"Validation of cutaneous dermatomyositis disease area and severity index activity score and other efficacy outcomes as measures of skin disease in dermatomyositis in the lenabasum phase 3 trial","volume":"143","author":"Pandya","year":"2023","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejphar.2026.179130_bib129","article-title":"Cannabinoids and drug\u2013drug pharmacokinetic interactions: deciphering the risks","volume":"70430","author":"Papakyriakopoulou","year":"2026","journal-title":"Br J Clin Pharmacol bcp"},{"key":"10.1016\/j.ejphar.2026.179130_bib130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2147\/CPAA.S115679","article-title":"Bioavailability study of dronabinol oral solution versus dronabinol capsules in healthy volunteers","volume":"8","author":"Parikh","year":"2016","journal-title":"CPAA"},{"key":"10.1016\/j.ejphar.2026.179130_bib131","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American heart association","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2026.179130_bib132","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1172\/JCI200318921","article-title":"C-reactive protein: a critical update","volume":"111","author":"Pepys","year":"2003","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2026.179130_bib133","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1126\/science.1171870","article-title":"Spinal endocannabinoids and CB1 receptors mediate C-Fiber\u2013Induced heterosynaptic pain sensitization","volume":"325","author":"Pern\u00eda-Andrade","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2026.179130_bib134","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0301-0082(00)00031-9","article-title":"Cannabinoid receptors and pain","volume":"63","author":"Pertwee","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejphar.2026.179130_bib135","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1038\/sj.ijo.0803272","article-title":"The pharmacology of cannabinoid receptors and their ligands: an overview","volume":"30","author":"Pertwee","year":"2006","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.ejphar.2026.179130_bib136","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.neuropharm.2006.08.011","article-title":"Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats","volume":"52","author":"Petrosino","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2026.179130_bib137","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40263-021-00879-w","article-title":"Cannabis-based medicines and medical cannabis for chronic neuropathic pain","volume":"36","author":"Petzke","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejphar.2026.179130_bib138","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s10194-012-0490-1","article-title":"Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial","volume":"13","author":"Pini","year":"2012","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.ejphar.2026.179130_bib139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/db2022-01","article-title":"Diagnosis and treatment of painful diabetic peripheral neuropathy","author":"Pop-Busui","year":"2022","journal-title":"Compendia"},{"key":"10.1016\/j.ejphar.2026.179130_bib140","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/14737175.2021.1935879","article-title":"Safety and tolerability of nabiximols oromucosal spray: a review of more than 15 years\u201d accumulated evidence from clinical trials","volume":"21","author":"Prieto Gonz\u00e1lez","year":"2021","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.ejphar.2026.179130_bib141","doi-asserted-by":"crossref","first-page":"12125","DOI":"10.1523\/JNEUROSCI.3400-08.2008","article-title":"Crucial role of CB2 cannabinoid receptor in the regulation of central immune responses during neuropathic pain","volume":"28","author":"Racz","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179130_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120728","article-title":"Pharmacological and biological effects of alpha-bisabolol: an updated review of the molecular mechanisms","volume":"304","author":"Ramazani","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2026.179130_bib143","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1097\/j.pain.0000000000001034","article-title":"Sensory phenotype and risk factors for painful diabetic neuropathy: a cross-sectional observational study","volume":"158","author":"Raputova","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2026.179130_bib144","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.2174\/092986710790980005","article-title":"Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown","volume":"17","author":"Reggio","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.179130_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2026.103986","article-title":"High-dose cannabidiol for chronic neuropathic pain associated with spinal cord injury: a randomised clinical trial","volume":"96","author":"Robertson","year":"2026","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.ejphar.2026.179130_bib146","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1212\/01.wnl.0000176753.45410.8b","article-title":"Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis","volume":"65","author":"Rog","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2026.179130_bib147","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejpain.2005.02.003","article-title":"Quantitative sensory testing: a comprehensive protocol for clinical trials","volume":"10","author":"Rolke","year":"2006","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.ejphar.2026.179130_bib148","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/phar.1642","article-title":"Peripherally restricted cannabinoids for the treatment of pain","volume":"35","author":"Romero-Sandoval","year":"2015","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejphar.2026.179130_bib149","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1186\/1744-8069-5-25","article-title":"CANnabinoid receptor type 2 activation induces a microglial anti-inflammatory phenotype and reduces migration via MKP induction and ERK dephosphorylation","volume":"5","author":"Romero-Sandoval","year":"2009","journal-title":"Mol. Pain"},{"key":"10.1016\/j.ejphar.2026.179130_bib150","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1089\/can.2016.0009","article-title":"Clinical endocannabinoid deficiency reconsidered: current research supports the theory in Migraine, fibromyalgia, irritable bowel, and other treatment-resistant syndromes","volume":"1","author":"Russo","year":"2016","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.ejphar.2026.179130_bib151","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1748-1716.2011.02280.x","article-title":"The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2\u2010arachidonoylglycerol signalling through cannabinoid receptors","volume":"204","author":"Savinainen","year":"2012","journal-title":"Acta Physiol."},{"key":"10.1016\/j.ejphar.2026.179130_bib152","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000542511","article-title":"Efficacy and safety of transdermal medical cannabis (THC:CBD: CBN formula) to treat painful diabetic peripheral neuropathy of the lower extremities","author":"Seevathee","year":"2024","journal-title":"Med. Cannabis Cannabinoids"},{"key":"10.1016\/j.ejphar.2026.179130_bib153","doi-asserted-by":"crossref","first-page":"7525","DOI":"10.1021\/acs.jmedchem.6b00516","article-title":"Peripherally selective cannabinoid 1 receptor (CB1R) agonists for the treatment of neuropathic pain","volume":"59","author":"Seltzman","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.179130_bib154","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2337\/dc09-1029","article-title":"Randomized placebo-controlled double-blind clinical trial of cannabis-based medicinal product (Sativex) in painful diabetic neuropathy","volume":"33","author":"Selvarajah","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2026.179130_bib155","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1002\/ejp.2016","article-title":"Cannabigerol (CBG) attenuates mechanical hypersensitivity elicited by chemotherapy\u2010induced peripheral neuropathy","volume":"26","author":"Sepulveda","year":"2022","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.ejphar.2026.179130_bib156","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/j.1532-2149.2013.00445.x","article-title":"A double\u2010blind, randomized, placebo\u2010controlled, parallel group study of THC\/CBD spray in peripheral neuropathic pain treatment","volume":"18","author":"Serpell","year":"2014","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.ejphar.2026.179130_bib157","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7812\/TPP\/18-041","article-title":"Cannabidiol in anxiety and sleep: a large case series","volume":"23","author":"Shannon","year":"2019","journal-title":"TPJ"},{"key":"10.1016\/j.ejphar.2026.179130_bib158","doi-asserted-by":"crossref","first-page":"8394","DOI":"10.1073\/pnas.082235799","article-title":"A missense mutation in human fatty acid amide hydrolase associated with problem drug use","volume":"99","author":"Sipe","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.ejphar.2026.179130_bib159","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.biopsych.2017.06.032","article-title":"Positive allosteric modulation of cannabinoid receptor type 1 suppresses pathological pain without producing tolerance or dependence","volume":"84","author":"Slivicki","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179130_bib160","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1474-4422(25)00068-7","article-title":"Pharmacotherapy and non-invasive neuromodulation for neuropathic pain: a systematic review and meta-analysis","volume":"24","author":"Soliman","year":"2025","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejphar.2026.179130_bib161","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/art.42510","article-title":"Efficacy and safety of lenabasum, a cannabinoid type 2 receptor agonist, in a phase 3 randomized trial in diffuse cutaneous systemic sclerosis","volume":"75","author":"Spiera","year":"2023","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.ejphar.2026.179130_bib162","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fnmol.2017.00174","article-title":"Pathophysiology of chemotherapy-induced peripheral neuropathy","volume":"10","author":"Starobova","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179130_bib163","series-title":"Advances in Pharmacology","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/bs.apha.2017.05.003","article-title":"Cannabinoids and pain: sites and mechanisms of action","author":"Starowicz","year":"2017"},{"key":"10.1016\/j.ejphar.2026.179130_bib164","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1097\/j.pain.0000000000001293","article-title":"Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies","volume":"159","author":"Stockings","year":"2018","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2026.179130_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2024.100311","article-title":"Long-term safety and efficacy of lenabasum, a cannabinoid receptor type 2 agonist, in patients with dermatomyositis with refractory skin disease: follow-up data from a 3-Year open-label extension study","volume":"5","author":"Stone","year":"2025","journal-title":"JID Innov"},{"key":"10.1016\/j.ejphar.2026.179130_bib166","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1111\/bph.15185","article-title":"A systematic review of minor phytocannabinoids with promising neuroprotective potential","volume":"177","author":"Stone","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179130_bib167","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.imbio.2009.12.005","article-title":"Cannabinoids and the immune system: an overview","volume":"215","author":"Tanasescu","year":"2010","journal-title":"Immunobiology"},{"key":"10.1016\/j.ejphar.2026.179130_bib168","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.neuron.2010.01.021","article-title":"The endocannabinoid 2-Arachidonoylglycerol produced by diacylglycerol lipase \u03b1 mediates retrograde suppression of synaptic transmission","volume":"65","author":"Tanimura","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2026.179130_bib169","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1513\/AnnalsATS.201212-127FR","article-title":"Effects of Marijuana smoking on the lung","volume":"10","author":"Tashkin","year":"2013","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.ejphar.2026.179130_bib170","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.pain.2012.06.024","article-title":"An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain","volume":"153","author":"Toth","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2026.179130_bib171","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1007\/s00018-016-2300-4","article-title":"The CB2 receptor and its role as a regulator of inflammation","volume":"73","author":"Turcotte","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejphar.2026.179130_bib172","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1126\/science.aaf7497","article-title":"Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474","volume":"356","author":"Van Esbroeck","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2026.179130_bib173","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.pain.2013.11.013","article-title":"Neuropathic pain in the general population: a systematic review of epidemiological studies","volume":"155","author":"van Hecke","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2026.179130_bib174","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMra1402309","article-title":"Adverse health effects of Marijuana use","volume":"370","author":"Volkow","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2026.179130_bib175","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1097\/j.pain.0000000000000935","article-title":"Stratifying patients with peripheral neuropathic pain based on sensory profiles: algorithm and sample size recommendations","volume":"158","author":"Vollert","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2026.179130_bib176","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.neuron.2012.02.008","article-title":"Deconstructing the neuropathic pain phenotype to reveal neural mechanisms","volume":"73","author":"von Hehn","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2026.179130_bib177","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3389\/fphar.2018.01259","article-title":"Cannabinoids and pain: new insights from old molecules","volume":"9","author":"Vu\u010dkovi\u0107","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179130_bib178","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.urology.2017.02.029","article-title":"Fatty acid amide hydrolase inhibitor treatment in men with chronic prostatitis\/chronic pelvic pain syndrome: an adaptive double-blind, randomized controlled trial","volume":"103","author":"Wagenlehner","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.ejphar.2026.179130_bib179","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jpain.2015.03.008","article-title":"Efficacy of inhaled cannabis on painful diabetic neuropathy","volume":"16","author":"Wallace","year":"2015","journal-title":"J. Pain"},{"key":"10.1016\/j.ejphar.2026.179130_bib180","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.777804","article-title":"Minor cannabinoids: biosynthesis, molecular pharmacology and potential therapeutic uses","volume":"12","author":"Walsh","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179130_bib181","doi-asserted-by":"crossref","first-page":"E694","DOI":"10.1503\/cmaj.091414","article-title":"Smoked cannabis for chronic neuropathic pain: a randomized controlled trial","volume":"182","author":"Ware","year":"2010","journal-title":"Canadian Medical Association Journal"},{"key":"10.1016\/j.ejphar.2026.179130_bib182","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nn.3602","article-title":"Regulating excitability of peripheral afferents: emerging ion channel targets","volume":"17","author":"Waxman","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179130_bib183","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1590168","article-title":"Combination CBD\/THC in the management of chemotherapy-induced peripheral neuropathy: a randomized double blind controlled trial","volume":"15","author":"Weiss","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejphar.2026.179130_bib184","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/jama.2015.6358","article-title":"Cannabinoids for medical use: a systematic review and meta-analysis","volume":"313","author":"Whiting","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2026.179130_bib185","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jpain.2012.10.009","article-title":"Low-dose vaporized cannabis significantly improves neuropathic pain","volume":"14","author":"Wilsey","year":"2013","journal-title":"J. Pain"},{"key":"10.1016\/j.ejphar.2026.179130_bib186","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jpain.2007.12.010","article-title":"A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain","volume":"9","author":"Wilsey","year":"2008","journal-title":"J. Pain"},{"key":"10.1016\/j.ejphar.2026.179130_bib187","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neuropharm.2017.06.015","article-title":"The cannabinoid system and pain","volume":"124","author":"Woodhams","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2026.179130_bib188","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.pain.2010.09.030","article-title":"Central sensitization: implications for the diagnosis and treatment of pain","volume":"152","author":"Woolf","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2026.179130_bib189","first-page":"390","article-title":"The effectiveness of topical cannabidiol oil in symptomatic relief of peripheral neuropathy of the lower extremities","volume":"21","author":"Xu","year":"2020","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejphar.2026.179130_bib190","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70184","article-title":"Cannabinoid receptor 2 facilitates the Schwann cells-dependent peripheral nerve regeneration","volume":"15","author":"Xu","year":"2025","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.ejphar.2026.179130_bib191","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.3390\/ijms24032348","article-title":"Microglial cannabinoid CB2 receptors in pain modulation","volume":"24","author":"Xu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179130_bib192","article-title":"The dynamic role of microglia and the endocannabinoid system in neuroinflammation","volume":"12","author":"Young","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179130_bib193","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1460-9568.2009.07075.x","article-title":"Cannabinoid CB1 receptor facilitation of substance P release in the rat spinal cord, measured as neurokinin 1 receptor internalization","volume":"31","author":"Zhang","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179130_bib194","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1046\/j.1460-9568.2003.02704.x","article-title":"Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models","volume":"17","author":"Zhang","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179130_bib195","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109233","article-title":"Peroxisome proliferator-activated receptor gamma agonist ELB00824 suppresses oxaliplatin-induced pain, neuronal hypersensitivity, and oxidative stress","volume":"218","author":"Zhang","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2026.179130_bib196","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/ejp.2072","article-title":"Oral capsules of tetra\u2010hydro\u2010cannabinol (THC), cannabidiol (CBD) and their combination in peripheral neuropathic pain treatment","volume":"27","author":"Zubcevic","year":"2023","journal-title":"Eur. J. Pain"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926006126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926006126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T22:06:13Z","timestamp":1786485973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926006126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":196,"alternative-id":["S0014299926006126"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179130","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabinoids in peripheral neuropathic pain: Resolving mechanistic mismatch through CB2-oriented phenotype stratification","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179130","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"179130"}}